Cancer Survivors Program
Recruiting · NCT07253987 · Interventional (participants receive a specific treatment) · Lead sponsor: Masaryk Memorial Cancer Institute
View the official record on ClinicalTrials.gov →Interventions studied
active screening of adverse effects of anticancer therapy based on specific questionnaire + quality of life screening
What this trial is about
The questionnaire for assessment of adverse events after completion of cancer treatment, which is being piloted at the Masaryk Memorial Cancer Institute, aims to detect a wide range of adverse effects early on, thus facilitating adequate intervention and planning of follow-up care for all cancer survivors.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- The patient understands the information provided and agrees to participate in the study.
- Age 18 years or older.
- Histologically confirmed invasive breast cancer or invasive prostate cancer.
- Completion of the acute phase of curative oncological therapy:
- for breast cancer: curative surgery performed + completed neoadjuvant/adjuvant chemotherapy and completed adjuvant radiotherapy, if indicated
- for prostate cancer: completed radiotherapy with curative intent or radical prostatectomy performed (open, laparoscopic, robotic) or completed adjuvant radiotherapy after prostatectomy
- The patient is available for follow-up within 12 months of enrollment in the study.
Exclusion criteria
- Active ongoing oncological therapy (except for (i) adjuvant hormone therapy, (ii) adjuvant targeted therapy (anti-HER2 therapy, CDK4/6i, PARPi, T-DM1), (iii) adjuvant immunotherapy)
- Neoadjuvant/adjuvant therapy did not include chemotherapy (breast cancer).
- Recurrence of cancer
- Metastatic disease
- History of other primary malignancy (except for non-melanoma skin cancer)
Where it is running
2 locations listed.
- Masaryk Memorial Cancer Institute - Brno, Czechia
- Masaryk Memorial Cancer Institute - Brno, Czechia